Mycophenolate Sodium (Myfortic®) in the Treatment of Corticosteroid-refractory Autoimmune Uveitis:Pilot Study
Status:
Unknown status
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
This study is designed to explore the use of Myfortic® in patients with steroid-refractory
uveitis. The aim of the study will be to show the therapeutic effect of Myfortic® in managing
uveitis patients.